CN105358095A - 不用结肠切除术治疗炎性肠病的方法和组合物 - Google Patents
不用结肠切除术治疗炎性肠病的方法和组合物 Download PDFInfo
- Publication number
- CN105358095A CN105358095A CN201480019982.7A CN201480019982A CN105358095A CN 105358095 A CN105358095 A CN 105358095A CN 201480019982 A CN201480019982 A CN 201480019982A CN 105358095 A CN105358095 A CN 105358095A
- Authority
- CN
- China
- Prior art keywords
- tissue
- ecm
- methods
- colon
- damage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 97
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 208000022559 Inflammatory bowel disease Diseases 0.000 title claims abstract description 21
- 238000012321 colectomy Methods 0.000 title claims description 11
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 164
- 210000002744 extracellular matrix Anatomy 0.000 claims abstract description 164
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 163
- 210000001519 tissue Anatomy 0.000 claims abstract description 129
- 210000000130 stem cell Anatomy 0.000 claims abstract description 44
- 206010009900 Colitis ulcerative Diseases 0.000 claims abstract description 36
- 201000006704 Ulcerative Colitis Diseases 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 29
- 230000012292 cell migration Effects 0.000 claims abstract description 5
- 210000001072 colon Anatomy 0.000 claims description 107
- 230000006378 damage Effects 0.000 claims description 54
- 238000011282 treatment Methods 0.000 claims description 42
- 210000004877 mucosa Anatomy 0.000 claims description 37
- 210000000813 small intestine Anatomy 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 22
- 239000000725 suspension Substances 0.000 claims description 22
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 20
- 201000010099 disease Diseases 0.000 claims description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
- 210000004876 tela submucosa Anatomy 0.000 claims description 17
- 238000005243 fluidization Methods 0.000 claims description 16
- 208000011231 Crohn disease Diseases 0.000 claims description 13
- 210000004400 mucous membrane Anatomy 0.000 claims description 13
- 230000000968 intestinal effect Effects 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000002679 ablation Methods 0.000 claims description 8
- 210000003405 ileum Anatomy 0.000 claims description 8
- 230000002757 inflammatory effect Effects 0.000 claims description 7
- 238000002054 transplantation Methods 0.000 claims description 6
- 241000792859 Enema Species 0.000 claims description 5
- 208000029664 classic familial adenomatous polyposis Diseases 0.000 claims description 5
- 239000007920 enema Substances 0.000 claims description 5
- 229940095399 enema Drugs 0.000 claims description 5
- 238000011065 in-situ storage Methods 0.000 claims description 5
- 210000004347 intestinal mucosa Anatomy 0.000 claims description 5
- 235000021476 total parenteral nutrition Nutrition 0.000 claims description 5
- 206010010539 Congenital megacolon Diseases 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 201000006107 Familial adenomatous polyposis Diseases 0.000 claims description 4
- 206010016717 Fistula Diseases 0.000 claims description 4
- 208000004592 Hirschsprung disease Diseases 0.000 claims description 4
- 206010036774 Proctitis Diseases 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 230000003890 fistula Effects 0.000 claims description 4
- 238000001990 intravenous administration Methods 0.000 claims description 4
- 206010009944 Colon cancer Diseases 0.000 claims description 3
- 208000029742 colonic neoplasm Diseases 0.000 claims description 3
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 2
- 206010038038 rectal cancer Diseases 0.000 claims 2
- 201000001275 rectum cancer Diseases 0.000 claims 2
- 210000002429 large intestine Anatomy 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 238000002271 resection Methods 0.000 abstract description 14
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 239000000499 gel Substances 0.000 description 51
- 239000000243 solution Substances 0.000 description 33
- 241000282472 Canis lupus familiaris Species 0.000 description 14
- 210000002249 digestive system Anatomy 0.000 description 14
- 239000007788 liquid Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000007943 implant Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 230000008520 organization Effects 0.000 description 9
- 230000000112 colonic effect Effects 0.000 description 8
- 238000001879 gelation Methods 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 210000004392 genitalia Anatomy 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 230000000241 respiratory effect Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 230000008846 dynamic interplay Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000000289 Esophageal Achalasia Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010015548 Euthanasia Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030136 Oesophageal achalasia Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 201000000621 achalasia Diseases 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000003872 anastomosis Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 210000001100 crypt cell Anatomy 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011833 dog model Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000012977 invasive surgical procedure Methods 0.000 description 2
- 238000002647 laser therapy Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000000505 pernicious effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000002428 photodynamic therapy Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 150000003673 urethanes Chemical class 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
- 229960005054 acepromazine Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- IFKLAQQSCNILHL-QHAWAJNXSA-N butorphanol Chemical compound N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 IFKLAQQSCNILHL-QHAWAJNXSA-N 0.000 description 1
- 229960001113 butorphanol Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940080133 omeprazole 20 mg Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010880 proctocolectomy Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011519 second-line treatment Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000002660 stem cell treatment Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000000659 thermocoagulation Effects 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3679—Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (32)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361809606P | 2013-04-08 | 2013-04-08 | |
US61/809,606 | 2013-04-08 | ||
US201361843286P | 2013-07-05 | 2013-07-05 | |
US61/843,286 | 2013-07-05 | ||
US201361901237P | 2013-11-07 | 2013-11-07 | |
US61/901,237 | 2013-11-07 | ||
PCT/US2014/033365 WO2014168964A1 (en) | 2013-04-08 | 2014-04-08 | Method and composition for treating inflammatory bowel disease without colectomy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105358095A true CN105358095A (zh) | 2016-02-24 |
CN105358095B CN105358095B (zh) | 2020-11-20 |
Family
ID=51689961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480019982.7A Expired - Fee Related CN105358095B (zh) | 2013-04-08 | 2014-04-08 | 不用结肠切除术治疗炎性肠病的方法和组合物 |
Country Status (14)
Country | Link |
---|---|
US (2) | US20160045552A1 (zh) |
EP (1) | EP2983616B1 (zh) |
JP (1) | JP6461096B2 (zh) |
KR (1) | KR102129562B1 (zh) |
CN (1) | CN105358095B (zh) |
AU (2) | AU2014251110A1 (zh) |
CA (1) | CA2907774C (zh) |
DK (1) | DK2983616T3 (zh) |
ES (1) | ES2703785T3 (zh) |
HK (1) | HK1221393A1 (zh) |
HU (1) | HUE042704T2 (zh) |
IL (1) | IL241910B (zh) |
PL (1) | PL2983616T3 (zh) |
WO (1) | WO2014168964A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109152635A (zh) * | 2016-03-14 | 2019-01-04 | 雷金蒂斯公司 | 治疗炎性肠病的方法和组合物 |
CN109199571A (zh) * | 2017-06-29 | 2019-01-15 | 柯惠有限合伙公司 | 用于消融治疗肠易激综合征的系统和方法 |
CN109715091A (zh) * | 2016-08-19 | 2019-05-03 | 雷金蒂斯公司 | 用于粘膜组织的组织重建的细胞外基质 |
CN112334169A (zh) * | 2018-06-21 | 2021-02-05 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为粘膜下流体垫 |
CN112334164A (zh) * | 2018-06-21 | 2021-02-05 | 联邦高等教育系统匹兹堡大学 | 膀胱ecm水凝胶作为食管粘膜下层流体垫的用途 |
CN112469449A (zh) * | 2018-06-21 | 2021-03-09 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2806505T3 (es) | 2014-03-21 | 2021-02-17 | Univ Pittsburgh Commonwealth Sys Higher Education | Procedimientos de preparación de un hidrogel esterilizado de modo terminal que proviene de matriz extracelular |
US20160000550A1 (en) * | 2014-07-05 | 2016-01-07 | Deborah Nagle | Methods for treating diseases of the colon |
US11291688B2 (en) | 2017-03-02 | 2022-04-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | Extracellular matrix (ECM) hydrogel and soluble fraction thereof for the treatment of cancer |
CA3052489A1 (en) | 2017-03-02 | 2018-09-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Ecm hydrogel for treating esophageal inflammation |
WO2019217812A1 (en) | 2018-05-11 | 2019-11-14 | Boston Scientific Scimed, Inc. | Devices, systems, and methods for tissue resection |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885619A (en) * | 1995-04-07 | 1999-03-23 | Purdue Research Foundation | Large area submucosal tissue graft constructs and method for making the same |
US20030059410A1 (en) * | 1999-12-22 | 2003-03-27 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
CN101366976A (zh) * | 2008-09-03 | 2009-02-18 | 陕西瑞盛生物科技有限公司 | 人源化异种细胞外基质材料及其制备方法 |
CN101404942A (zh) * | 2005-04-29 | 2009-04-08 | 库克生物科技公司 | 治疗瘘的立体移植物和相关方法与系统 |
US20090204228A1 (en) * | 2003-09-04 | 2009-08-13 | Hiles Michael C | Extracellular matrix composite materials, and manufacture and use thereof |
CN101626791A (zh) * | 2007-03-07 | 2010-01-13 | 科洛普拉斯特公司 | 包含ecm的网片 |
US20100275280A1 (en) * | 2007-08-10 | 2010-10-28 | Hubrecht Institute | Method for identifying, expanding and removing adult stem cells and cancer stem cells |
CN102027013A (zh) * | 2008-04-24 | 2011-04-20 | 株式会社遗传科技 | 细胞外基质蛋白的氨基酸序列rgd的特异性人源化抗体及其应用 |
CN102112162A (zh) * | 2008-06-20 | 2011-06-29 | 库克生物科技公司 | 复合细胞外基质材料及由其形成的医疗产品 |
CN102256609A (zh) * | 2008-07-30 | 2011-11-23 | 米辛瑟斯有限公司 | 衍生自前胃胞外基质的组织支架 |
WO2012003450A2 (en) * | 2010-07-02 | 2012-01-05 | The University Of North Carolina At Chapel Hill | Biomatrix scaffolds |
CN102395381A (zh) * | 2009-02-18 | 2012-03-28 | 矩阵心血管疾病有限公司 | 用于预防心律失常的组合物和方法 |
WO2012064606A2 (en) * | 2010-11-10 | 2012-05-18 | Wake Forest University Health Sciences | Tissue-specific extracellular matrix with or without tissue protein components for cell culture |
CN102470189A (zh) * | 2009-07-06 | 2012-05-23 | 科洛普拉斯特公司 | 用于软组织再生的生物可降解性支架及其用途 |
CN102552910A (zh) * | 2010-12-31 | 2012-07-11 | 中国科学院上海生命科学研究院 | 细胞外基质蛋白1及其调节剂在制备过敏性疾病诊断或治疗药物中的应用 |
WO2012114333A1 (en) * | 2011-02-24 | 2012-08-30 | Ilan Ben Oren | Hybrid catheter for vascular intervention |
CN102712921A (zh) * | 2009-09-24 | 2012-10-03 | 株式会社遗传科技 | 特异用于胞外基质蛋白的氨基酸序列rgd的人源化抗体及其用途 |
CN102946915A (zh) * | 2010-05-25 | 2013-02-27 | 库克生物技术股份有限公司 | 用于医疗移植物的细胞接种的方法、基底和系统 |
US20130058991A1 (en) * | 2009-10-09 | 2013-03-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Matricryptic ecm peptides for tissue reconstruction |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817662A (en) * | 1992-11-09 | 1998-10-06 | Cell Therapeutics, Inc. | Substituted amino alkyl compounds |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US6974796B1 (en) * | 1999-08-17 | 2005-12-13 | Girsh Leonard S | Therapeutic compositions for treatment of a damaged tissue |
US5554389A (en) | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
SE9602644D0 (sv) * | 1996-07-04 | 1996-07-04 | Astra Ab | New use |
AU2007210970B2 (en) * | 2006-01-31 | 2013-09-05 | Cook Biotech Incorporated | Fistula grafts and related methods and systems for treating fistulae |
US8084023B2 (en) | 2007-01-22 | 2011-12-27 | The Board Of Trustees Of The University Of Arkansas | Maintenance and propagation of mesenchymal stem cells |
WO2012002986A2 (en) * | 2009-12-21 | 2012-01-05 | The Regents Of The University Of California | Decellularized and delipidized extracellular matrix and methods of use |
JP2011246461A (ja) * | 2010-04-27 | 2011-12-08 | Mitsubishi Tanabe Pharma Corp | 新規アミド誘導体を含有する医薬組成物 |
CN105050630A (zh) * | 2013-03-15 | 2015-11-11 | 库克医药技术有限责任公司 | 粘合剂医学产品和治疗胃肠病损的方法 |
-
2014
- 2014-04-08 KR KR1020157032025A patent/KR102129562B1/ko active IP Right Grant
- 2014-04-08 CN CN201480019982.7A patent/CN105358095B/zh not_active Expired - Fee Related
- 2014-04-08 US US14/782,887 patent/US20160045552A1/en not_active Abandoned
- 2014-04-08 DK DK14783373.5T patent/DK2983616T3/en active
- 2014-04-08 AU AU2014251110A patent/AU2014251110A1/en not_active Abandoned
- 2014-04-08 HU HUE14783373A patent/HUE042704T2/hu unknown
- 2014-04-08 WO PCT/US2014/033365 patent/WO2014168964A1/en active Application Filing
- 2014-04-08 ES ES14783373T patent/ES2703785T3/es active Active
- 2014-04-08 CA CA2907774A patent/CA2907774C/en active Active
- 2014-04-08 JP JP2016507614A patent/JP6461096B2/ja active Active
- 2014-04-08 EP EP14783373.5A patent/EP2983616B1/en not_active Not-in-force
- 2014-04-08 PL PL14783373T patent/PL2983616T3/pl unknown
-
2015
- 2015-10-06 IL IL241910A patent/IL241910B/en active IP Right Grant
-
2016
- 2016-08-10 HK HK16109488.2A patent/HK1221393A1/zh unknown
- 2016-11-03 US US15/343,138 patent/US20170112964A1/en not_active Abandoned
-
2019
- 2019-05-13 AU AU2019203323A patent/AU2019203323B2/en not_active Ceased
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885619A (en) * | 1995-04-07 | 1999-03-23 | Purdue Research Foundation | Large area submucosal tissue graft constructs and method for making the same |
US20030059410A1 (en) * | 1999-12-22 | 2003-03-27 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
US20090204228A1 (en) * | 2003-09-04 | 2009-08-13 | Hiles Michael C | Extracellular matrix composite materials, and manufacture and use thereof |
CN101404942A (zh) * | 2005-04-29 | 2009-04-08 | 库克生物科技公司 | 治疗瘘的立体移植物和相关方法与系统 |
CN101626791A (zh) * | 2007-03-07 | 2010-01-13 | 科洛普拉斯特公司 | 包含ecm的网片 |
US20100275280A1 (en) * | 2007-08-10 | 2010-10-28 | Hubrecht Institute | Method for identifying, expanding and removing adult stem cells and cancer stem cells |
CN102027013A (zh) * | 2008-04-24 | 2011-04-20 | 株式会社遗传科技 | 细胞外基质蛋白的氨基酸序列rgd的特异性人源化抗体及其应用 |
CN102112162A (zh) * | 2008-06-20 | 2011-06-29 | 库克生物科技公司 | 复合细胞外基质材料及由其形成的医疗产品 |
CN102256609A (zh) * | 2008-07-30 | 2011-11-23 | 米辛瑟斯有限公司 | 衍生自前胃胞外基质的组织支架 |
CN101366976A (zh) * | 2008-09-03 | 2009-02-18 | 陕西瑞盛生物科技有限公司 | 人源化异种细胞外基质材料及其制备方法 |
CN102395381A (zh) * | 2009-02-18 | 2012-03-28 | 矩阵心血管疾病有限公司 | 用于预防心律失常的组合物和方法 |
CN102470189A (zh) * | 2009-07-06 | 2012-05-23 | 科洛普拉斯特公司 | 用于软组织再生的生物可降解性支架及其用途 |
CN102712921A (zh) * | 2009-09-24 | 2012-10-03 | 株式会社遗传科技 | 特异用于胞外基质蛋白的氨基酸序列rgd的人源化抗体及其用途 |
US20130058991A1 (en) * | 2009-10-09 | 2013-03-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Matricryptic ecm peptides for tissue reconstruction |
CN102946915A (zh) * | 2010-05-25 | 2013-02-27 | 库克生物技术股份有限公司 | 用于医疗移植物的细胞接种的方法、基底和系统 |
WO2012003450A2 (en) * | 2010-07-02 | 2012-01-05 | The University Of North Carolina At Chapel Hill | Biomatrix scaffolds |
WO2012064606A2 (en) * | 2010-11-10 | 2012-05-18 | Wake Forest University Health Sciences | Tissue-specific extracellular matrix with or without tissue protein components for cell culture |
CN102552910A (zh) * | 2010-12-31 | 2012-07-11 | 中国科学院上海生命科学研究院 | 细胞外基质蛋白1及其调节剂在制备过敏性疾病诊断或治疗药物中的应用 |
WO2012114333A1 (en) * | 2011-02-24 | 2012-08-30 | Ilan Ben Oren | Hybrid catheter for vascular intervention |
Non-Patent Citations (1)
Title |
---|
GIACOMO LANZONI,GIULIA RODA,ANDREA BELLUZZI,ENRICO RODA: "Inflammatory bowel disease: Moving toward a stem cell-based therapy", 《WORLD J GASTROENTEROL》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109152635A (zh) * | 2016-03-14 | 2019-01-04 | 雷金蒂斯公司 | 治疗炎性肠病的方法和组合物 |
CN109715091A (zh) * | 2016-08-19 | 2019-05-03 | 雷金蒂斯公司 | 用于粘膜组织的组织重建的细胞外基质 |
CN109199571A (zh) * | 2017-06-29 | 2019-01-15 | 柯惠有限合伙公司 | 用于消融治疗肠易激综合征的系统和方法 |
CN112334169A (zh) * | 2018-06-21 | 2021-02-05 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为粘膜下流体垫 |
CN112334164A (zh) * | 2018-06-21 | 2021-02-05 | 联邦高等教育系统匹兹堡大学 | 膀胱ecm水凝胶作为食管粘膜下层流体垫的用途 |
CN112469449A (zh) * | 2018-06-21 | 2021-03-09 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途 |
CN112334164B (zh) * | 2018-06-21 | 2022-08-19 | 联邦高等教育系统匹兹堡大学 | 膀胱ecm水凝胶作为食管粘膜下层流体垫的用途 |
CN115487364A (zh) * | 2018-06-21 | 2022-12-20 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为粘膜下流体垫 |
CN115487364B (zh) * | 2018-06-21 | 2024-02-23 | 联邦高等教育系统匹兹堡大学 | 细胞外基质(ecm)水凝胶作为粘膜下流体垫 |
Also Published As
Publication number | Publication date |
---|---|
AU2019203323A1 (en) | 2019-05-30 |
EP2983616B1 (en) | 2018-10-03 |
JP6461096B2 (ja) | 2019-01-30 |
US20160045552A1 (en) | 2016-02-18 |
KR102129562B1 (ko) | 2020-07-03 |
US20170112964A1 (en) | 2017-04-27 |
EP2983616A1 (en) | 2016-02-17 |
AU2019203323B2 (en) | 2020-10-08 |
EP2983616A4 (en) | 2016-08-31 |
HUE042704T2 (hu) | 2019-07-29 |
CA2907774C (en) | 2022-11-01 |
JP2016520560A (ja) | 2016-07-14 |
AU2014251110A1 (en) | 2015-11-26 |
PL2983616T3 (pl) | 2019-05-31 |
CA2907774A1 (en) | 2014-10-16 |
WO2014168964A1 (en) | 2014-10-16 |
CN105358095B (zh) | 2020-11-20 |
KR20160016778A (ko) | 2016-02-15 |
ES2703785T3 (es) | 2019-03-12 |
IL241910B (en) | 2021-04-29 |
DK2983616T3 (en) | 2019-01-21 |
HK1221393A1 (zh) | 2017-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105358095A (zh) | 不用结肠切除术治疗炎性肠病的方法和组合物 | |
US20210093751A1 (en) | Method and composition for treating inflammatory bowel disease | |
JP5607176B2 (ja) | 新規ペプチドおよびその用途 | |
CN103079577A (zh) | 伤口修复剂组合物的制备工艺、管子及装置 | |
KR20140091585A (ko) | 주사가능한 실크 피브로인 발포체 및 그의 용도 | |
CN103251987A (zh) | 一种脱细胞生物补片及其制备方法和装置 | |
CN108159496B (zh) | 一种双因子程序释放的仿生取向软骨支架及其制备方法 | |
MXPA04011043A (es) | Tratamientos con fibrolasto antologo. | |
KR20190055088A (ko) | 점막 조직의 조직 재구성을 위한 세포외 매트릭스 | |
CN102895702B (zh) | 一种复合人工胆管及其制备方法 | |
WO2017101027A1 (zh) | 改良的生物医用材料产品 | |
CN101347638A (zh) | 可注射用的组织修补材料及其制备方法 | |
CN101721262A (zh) | 组织工程化组合式人体腔管代用品 | |
CN102170934A (zh) | 用于手术治疗影响脊髓的过度增生疾病的医疗设备 | |
Wang et al. | Progress in the research and development of nerve conduits | |
Lai et al. | Combining Piezoelectric Stimulation and Extracellular Vesicles for Cartilage Regeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1221393 Country of ref document: HK |
|
CB02 | Change of applicant information |
Address after: American Florida Applicant after: Regentis Applicant after: University OF PITTSBURGH Address before: American Florida Applicant before: ASANA MEDICAL Inc. Applicant before: University OF PITTSBURGH |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201120 |
|
CF01 | Termination of patent right due to non-payment of annual fee |